Alevaire inhalation for eliminating secretions in asthma, sinusitis, bronchitis and bronchiectasis of adults; a preliminary report.
D000336:Aerosols / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D001987:Bronchiectasis / Q000628:therapy*; D001991:Bronchitis / Q000628:therapy*; D006801:Humans; D011092:Polyethylene Glycols; D012852:Sinusitis / Q000628:therapy*
D000336:Aerosols; D011092:Polyethylene Glycols; C016811:tyloxapol
AEROSOLS/therapeutic use; ASTHMA/therapy; BRONCHIECTASIS/therapy; BRONCHITIS/therapy; SINUSITIS/therapy